KR20220038344A - 통증과 관련된 수면 장애를 치료하는 방법 - Google Patents

통증과 관련된 수면 장애를 치료하는 방법 Download PDF

Info

Publication number
KR20220038344A
KR20220038344A KR1020227001869A KR20227001869A KR20220038344A KR 20220038344 A KR20220038344 A KR 20220038344A KR 1020227001869 A KR1020227001869 A KR 1020227001869A KR 20227001869 A KR20227001869 A KR 20227001869A KR 20220038344 A KR20220038344 A KR 20220038344A
Authority
KR
South Korea
Prior art keywords
sleep
pain
fmsd
compound
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020227001869A
Other languages
English (en)
Korean (ko)
Inventor
폴 블라훈카
제라드 마레크
캐서린 트레이시
메리 베스 블라우트
마이클 스미스
마크 왈저
마르시 잉글리시
Original Assignee
아스텔라스 파마 글로벌 디벨롭먼트, 인크.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 아스텔라스 파마 글로벌 디벨롭먼트, 인크. filed Critical 아스텔라스 파마 글로벌 디벨롭먼트, 인크.
Publication of KR20220038344A publication Critical patent/KR20220038344A/ko
Ceased legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1020227001869A 2019-07-23 2020-07-22 통증과 관련된 수면 장애를 치료하는 방법 Ceased KR20220038344A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962877573P 2019-07-23 2019-07-23
US62/877,573 2019-07-23
PCT/US2020/043047 WO2021016338A1 (en) 2019-07-23 2020-07-22 Methods of treating sleep disorders associated with pain

Publications (1)

Publication Number Publication Date
KR20220038344A true KR20220038344A (ko) 2022-03-28

Family

ID=72047043

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020227001869A Ceased KR20220038344A (ko) 2019-07-23 2020-07-22 통증과 관련된 수면 장애를 치료하는 방법

Country Status (10)

Country Link
US (1) US20220370468A1 (https=)
EP (1) EP4003357A1 (https=)
JP (1) JP2022541634A (https=)
KR (1) KR20220038344A (https=)
CN (1) CN114144183A (https=)
AU (1) AU2020318996A1 (https=)
BR (1) BR112022001056A2 (https=)
CA (1) CA3147752A1 (https=)
MX (1) MX2022000892A (https=)
WO (1) WO2021016338A1 (https=)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0320637D0 (en) * 2003-09-03 2003-10-01 Novartis Ag Organic compounds
MX350745B (es) * 2009-11-06 2017-09-14 Sk Biopharmaceuticals Co Ltd * El uso de un compuesto de carbamoilo para el tratamiento del sindrome de fibromialgia.
SG11201509989VA (en) * 2013-06-06 2016-01-28 Astellas Pharma Inc Benzothiophene compound

Also Published As

Publication number Publication date
BR112022001056A2 (pt) 2022-05-24
JP2022541634A (ja) 2022-09-26
MX2022000892A (es) 2022-03-11
AU2020318996A1 (en) 2022-02-03
CA3147752A1 (en) 2021-01-28
CN114144183A (zh) 2022-03-04
EP4003357A1 (en) 2022-06-01
WO2021016338A1 (en) 2021-01-28
US20220370468A1 (en) 2022-11-24

Similar Documents

Publication Publication Date Title
Backonja et al. Pharmacologic management part 1: better-studied neuropathic pain diseases
Jongen et al. Neuropathic pain and pharmacological treatment
US20250177378A1 (en) Treatment of depression
WO2016062285A1 (zh) 神经系统疾病用药在制备抗癌医药组合物中的应用
Chitneni et al. Use of ketamine infusions for treatment of complex regional pain syndrome: a systematic review
Brown et al. Modafinil for the treatment of multiple sclerosis-related fatigue
Hosseini et al. Acute pain management for older adults
Hauer et al. Pediatric pain and symptom management guidelines
Falup-Pecurariu et al. Pharmacological and non-pharmacological management of sleep disturbances in Parkinson’s disease: if when and how
Khandelwal et al. Dilated pupil as a diagnostic component of brain death—does it really matter?
Emir et al. Tramadol versus low dose tramadol‐paracetamol for patient controlled analgesia during spinal vertebral surgery
KR20220038344A (ko) 통증과 관련된 수면 장애를 치료하는 방법
Gleeson Symptom control in palliative care
O’Neil Pain management
US20250367212A1 (en) Pharmacotherapy for obsessive-compulsive disorder targeting dopamine d1 signal in striatal striosomes
US20220265666A1 (en) Methods of treating substance abuse disorder, dyspnea, tinnitus, and child and adolescent depression
Krtinić et al. Comparative Pharmacoepidemiological Analysis on Analgesics Consumption in the Republic of Serbia and Nordic Countries in the Period 2015-2018
RU2814528C1 (ru) Способ прогнозирования анальгетической эффективности антиконвульсантов инфузией трифосаденина у онкологических пациентов с интенсивной болью
Kapoor et al. Challenges in the management of cancer pain in elderly population: A review
Hemraj et al. Persistent Pain in the Older Adult: Practical Considerations for
Rhee et al. Treatment of severe pain in a patient with complex regional pain syndrome undergoing dental treatment under general anesthesia: A case report
Zhang et al. Unmet needs and future directions of treatment options for chronic cough
Yaukey et al. Management of Small Fiber Neuropathy: A Clinical Perspective
Bywood et al. Use of ketamine for persistent pain
Gowan et al. Disease state management: Pain management in older people-in aged care facilities and in the community

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

D21 Rejection of application intended

Free format text: ST27 STATUS EVENT CODE: A-1-2-D10-D21-EXM-PE0902 (AS PROVIDED BY THE NATIONAL OFFICE)

PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

B15 Application refused following examination

Free format text: ST27 STATUS EVENT CODE: N-2-6-B10-B15-EXM-PE0601 (AS PROVIDED BY THE NATIONAL OFFICE)

PE0601 Decision on rejection of patent

St.27 status event code: N-2-6-B10-B15-exm-PE0601